vs
Side-by-side financial comparison of DESTINATION XL GROUP, INC. (DXLG) and Esperion Therapeutics, Inc. (ESPR). Click either name above to swap in a different company.
Esperion Therapeutics, Inc. is the larger business by last-quarter revenue ($168.4M vs $101.9M, roughly 1.7× DESTINATION XL GROUP, INC.). On growth, Esperion Therapeutics, Inc. posted the faster year-over-year revenue change (143.7% vs -5.2%). Over the past eight quarters, Esperion Therapeutics, Inc.'s revenue compounded faster (10.6% CAGR vs -13.8%).
Destination XL Group, Inc. (DXLG) is a leading retailer of Men's Big and Tall apparel with 290 retail and outlet store locations throughout the United States operated under the business subsidiaries DXL and Casual Male XL. The company also operates an e-commerce website (dxl.com) and an Android and iOS mobile app serving customers in the United States, Canada, The United Kingdom, Greater China and other global markets. The company is headquartered in Canton, Massachusetts, and is listed on th...
Esperion Therapeutics, Inc. is a publicly traded American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. The company is headquartered in Ann Arbor, Michigan.
DXLG vs ESPR — Head-to-Head
Income Statement — Q3 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $101.9M | $168.4M |
| Net Profit | $-4.1M | — |
| Gross Margin | 42.7% | — |
| Operating Margin | -5.6% | 50.6% |
| Net Margin | -4.0% | — |
| Revenue YoY | -5.2% | 143.7% |
| Net Profit YoY | -128.3% | — |
| EPS (diluted) | $-0.08 | $0.32 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $101.9M | $168.4M | ||
| Q3 25 | $115.5M | $87.3M | ||
| Q2 25 | $105.5M | $82.4M | ||
| Q1 25 | $119.2M | $65.0M | ||
| Q4 24 | $107.5M | $69.1M | ||
| Q3 24 | $124.8M | $51.6M | ||
| Q2 24 | $115.5M | $73.8M | ||
| Q1 24 | $137.1M | $137.7M |
| Q4 25 | $-4.1M | — | ||
| Q3 25 | $-265.0K | $-31.3M | ||
| Q2 25 | $-1.9M | $-12.7M | ||
| Q1 25 | $-1.3M | $-40.5M | ||
| Q4 24 | $-1.8M | — | ||
| Q3 24 | $2.4M | $-29.5M | ||
| Q2 24 | $3.8M | $-61.9M | ||
| Q1 24 | $5.2M | $61.0M |
| Q4 25 | 42.7% | — | ||
| Q3 25 | 45.2% | — | ||
| Q2 25 | 45.1% | — | ||
| Q1 25 | 44.4% | — | ||
| Q4 24 | 45.1% | — | ||
| Q3 24 | 48.2% | — | ||
| Q2 24 | 48.2% | — | ||
| Q1 24 | 47.0% | — |
| Q4 25 | -5.6% | 50.6% | ||
| Q3 25 | 0.6% | -11.4% | ||
| Q2 25 | -3.3% | 8.6% | ||
| Q1 25 | -1.5% | -34.0% | ||
| Q4 24 | -2.4% | -6.4% | ||
| Q3 24 | 2.5% | -31.0% | ||
| Q2 24 | 4.2% | 3.5% | ||
| Q1 24 | 5.9% | 52.5% |
| Q4 25 | -4.0% | — | ||
| Q3 25 | -0.2% | -35.9% | ||
| Q2 25 | -1.8% | -15.4% | ||
| Q1 25 | -1.1% | -62.2% | ||
| Q4 24 | -1.7% | — | ||
| Q3 24 | 1.9% | -57.2% | ||
| Q2 24 | 3.3% | -83.9% | ||
| Q1 24 | 3.8% | 44.3% |
| Q4 25 | $-0.08 | $0.32 | ||
| Q3 25 | $0.00 | $-0.16 | ||
| Q2 25 | $-0.04 | $-0.06 | ||
| Q1 25 | $-0.02 | $-0.21 | ||
| Q4 24 | $-0.03 | $-0.14 | ||
| Q3 24 | $0.04 | $-0.15 | ||
| Q2 24 | $0.06 | $-0.33 | ||
| Q1 24 | $0.08 | $0.34 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $27.0M | $167.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $137.2M | $-302.0M |
| Total Assets | $401.5M | $465.9M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $27.0M | $167.9M | ||
| Q3 25 | $33.5M | $92.4M | ||
| Q2 25 | $29.1M | $86.1M | ||
| Q1 25 | $48.4M | $114.6M | ||
| Q4 24 | $43.0M | $144.8M | ||
| Q3 24 | $63.2M | $144.7M | ||
| Q2 24 | $53.2M | $189.3M | ||
| Q1 24 | $60.0M | $226.6M |
| Q4 25 | $137.2M | $-302.0M | ||
| Q3 25 | $140.9M | $-451.4M | ||
| Q2 25 | $140.7M | $-433.5M | ||
| Q1 25 | $141.2M | $-426.2M | ||
| Q4 24 | $145.5M | $-388.7M | ||
| Q3 24 | $157.0M | $-370.2M | ||
| Q2 24 | $153.6M | $-344.2M | ||
| Q1 24 | $149.0M | $-294.3M |
| Q4 25 | $401.5M | $465.9M | ||
| Q3 25 | $408.8M | $364.0M | ||
| Q2 25 | $380.1M | $347.1M | ||
| Q1 25 | $381.0M | $324.0M | ||
| Q4 24 | $381.3M | $343.8M | ||
| Q3 24 | $383.8M | $314.1M | ||
| Q2 24 | $376.6M | $352.3M | ||
| Q1 24 | $357.7M | $373.1M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-1.1M | $45.2M |
| Free Cash FlowOCF − Capex | $-6.0M | — |
| FCF MarginFCF / Revenue | -5.9% | — |
| Capex IntensityCapex / Revenue | 4.8% | 0.0% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-11.4M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-1.1M | $45.2M | ||
| Q3 25 | $9.9M | $-4.3M | ||
| Q2 25 | $-12.0M | $-31.4M | ||
| Q1 25 | $17.1M | $-22.6M | ||
| Q4 24 | $-3.5M | $-35.0M | ||
| Q3 24 | $17.1M | $-35.3M | ||
| Q2 24 | $-1.1M | $-7.2M | ||
| Q1 24 | $16.5M | $53.8M |
| Q4 25 | $-6.0M | — | ||
| Q3 25 | $4.6M | — | ||
| Q2 25 | $-18.8M | — | ||
| Q1 25 | $8.8M | — | ||
| Q4 24 | $-10.1M | — | ||
| Q3 24 | $10.2M | $-35.5M | ||
| Q2 24 | $-7.0M | $-7.3M | ||
| Q1 24 | $9.5M | $53.8M |
| Q4 25 | -5.9% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | -17.8% | — | ||
| Q1 25 | 7.4% | — | ||
| Q4 24 | -9.4% | — | ||
| Q3 24 | 8.2% | -68.7% | ||
| Q2 24 | -6.1% | -9.9% | ||
| Q1 24 | 6.9% | 39.0% |
| Q4 25 | 4.8% | 0.0% | ||
| Q3 25 | 4.6% | 0.0% | ||
| Q2 25 | 6.4% | 0.0% | ||
| Q1 25 | 7.0% | 0.0% | ||
| Q4 24 | 6.2% | 0.0% | ||
| Q3 24 | 5.5% | 0.3% | ||
| Q2 24 | 5.1% | 0.1% | ||
| Q1 24 | 5.1% | 0.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 7.17× | — | ||
| Q2 24 | -0.30× | — | ||
| Q1 24 | 3.15× | 0.88× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
DXLG
| Sales Channel Through Intermediary | $74.5M | 73% |
| Sales Channel Directly To Consumer | $27.3M | 27% |
ESPR
| Collaboration Revenue | $124.7M | 74% |
| Products | $43.7M | 26% |
